Department of Surgery, Seoul National University Bundang Hospital
Seongnam, 463-707, South Korea
NCT Number: NCT00606983
Various adrenergic blockers are used for acute voiding difficulty after proctectomy. Recently, a selective alpha5-adrenergic blocker, Tamsulosin has been reported to have benefit in reducing urinary symptom score and in reducing the rate of intermittent self-catheterization for patients with rectal cancer after radical proctectomy.
This study is to evaluate the efficacy of pharmacologic prevention to ameliorate the incidence of postoperative urinary dysfunction.
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Phase 3
Seongnam, 463-707, South Korea
Acute voiding difficulty is caused from damage to pelvic sympathetic nerve after rectal surgery, and usually resolved spontaneously within several months after the surgery. However, acute voiding difficulty results in prolonged insertion of urinary catheter and is associated risk for urinary tract infection. Various adrenergic blockers are used for acute voiding difficulty after proctectomy. Recently, a selective alpha5-adrenergic blocker, Tamsulosin has been reported to have benefit in reducing urinary symptom score and in reducing the rate of intermittent self-catheterization for patients with rectal cancer after radical proctectomy.
This study is to evaluate the efficacy of pharmacologic prevention to ameliorate teh incidence of postoperative urinary dysfunction.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
oral administration of Tamsulosin
Time frame: after removal of urinary catheter
Time frame: at postoperative day 7
Seoul National University Hospital
Other
Prevention of Acute Voiding Difficulty After Radical Proctectomy for Rectal Cancer With Tamsulosin
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07346586
Colorectal Neoplasms, Digestive System Diseases
Changchun, Jilin, China
View Trial DetailsNCT06241703
Colorectal Neoplasms, Digestive System Diseases
Changchun, Jilin, China
View Trial DetailsNCT06147492
Colorectal Neoplasms, Digestive System Diseases
View Trial DetailsNCT07736131
Colon Cancer, Colonic Diseases
View Trial Details